Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
PulmoSeek Lung Cancer Early Detection Assay
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
AnchorDx
Type:
CE Marked
Related tests:
‹
AnchorAIM® 10 Gene Test for Individualized Treatment of Lung Cancer
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
AnchorAIM® Personalized Treatment of Colorectal Cancer 11 Gene Test
AnchorIRIS™
UriFind® Methylation Test
AnchorAIM® 10 Gene Test for Individualized Treatment of Lung Cancer
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
AnchorAIM® Personalized Treatment of Colorectal Cancer 11 Gene Test
AnchorIRIS™
UriFind® Methylation Test
›
Details
Evidence
News
Filter by
Latest
over2years
AnchorDx receives CE Mark for lung cancer early diagnosis test (Genomeweb)
"AnchorDx said Wednesday that its PulmoSeek lung cancer early detection assay, has received CE marking, with a reagents license issued by the Netherlands' CIBG of Ministry of Health, Welfare, and Sport."
over 2 years ago
European regulatory
|
PulmoSeek Lung Cancer Early Detection Assay
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login